RecruitingNot ApplicableNCT07033104
Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section
Analgesic Effect of Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section, A Prospective Randomized Study
Sponsor
Tanta University
Enrollment
70 participants
Start Date
Apr 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Evaluate calcitonin as an adjuvant to bupivacaine in ultrasound guided tansversalis fascia plane block
Eligibility
Sex: FEMALE
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying us guided Transversalis fascia plane block for people with transversalis fascia plane block. The study is currently recruiting participants at 1 location. People eligible for this study include women.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERus guided Transversalis fascia plane block
addition of calcitonin to pubivacaine
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07033104
Related Trials
Transversalis Fascia Plane Versus Transversus Abdominis Plane Block for Postoperative Analgesia in Children
NCT072421961 location
Transversalis Fascia Plane Block Versus Intrathecal Morphine for Postoperative Analgesia in Total Abdominal Hysterectomy
NCT072012721 location
Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section
NCT071702671 location